Skip to main content

Table 1 Characteristics and treatments of the subjects at baseline

From: Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

Variable

Value

Number

12

Sex (male/female)

5/7

Age (years)

59.5 ± 9.4

Antidiabetic treatments

 

Diet alone

2

Oral hypoglycemic agents

10

Sulfonylurea

2

Glinide

3

Metformin

3

α-glucosidase inhibitor

5

Dipeptidyl peptidase-4 inhibitor

5

Thiazolidinedione

0

Insulin

0

Hypolipidemic agents

 

Fenofibrate

0

Statin

1

Ezetimibe

4

None

7

  1. Data are shown as the mean ± standard deviation or n.